Evidence map›Paper›PMID 30532669›Full record

ArticleCurrent nanoscience2018

Suggested Procedures for the Reproducible Synthesis of Poly(d,l-lactide-co-glycolide) Nanoparticles Using the Emulsification Solvent Diffusion Platform.

Shadabul Haque, Ben J Boyd, Michelle P McIntosh, Colin W Pouton, Lisa M Kaminskas, Michael Whittaker

Abstract read
In one paragraph

Article in Current nanoscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. How PLGA Microspheres are Emerging as a Key Drug Delivery System.International journal of nanomedicine · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Car@PLGA-NPs target gut microbiota-ER stress axis to combat diabetes.Frontiers in cellular and infection microbiology · 2025
    Article
  8. Swarms of Enzymatic Nanobots for Efficient Gene Delivery.ACS applied materials & interfaces · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Parasitology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shadabul Haque1Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Pde, ParkvilleVIC, 3052, Australia; 2ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Melbourne, VIC, 3052, Australia; 3School of Biomedical Sciences, University of Queensland, St LuciaQLD, 4072, Australia.
Ben J Boyd1Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Pde, ParkvilleVIC, 3052, Australia; 2ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Melbourne, VIC, 3052, Australia; 3School of Biomedical Sciences, University of Queensland, St LuciaQLD, 4072, Australia.
Michelle P McIntosh1Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Pde, ParkvilleVIC, 3052, Australia; 2ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Melbourne, VIC, 3052, Australia; 3School of Biomedical Sciences, University of Queensland, St LuciaQLD, 4072, Australia.
Colin W Pouton1Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Pde, ParkvilleVIC, 3052, Australia; 2ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Melbourne, VIC, 3052, Australia; 3School of Biomedical Sciences, University of Queensland, St LuciaQLD, 4072, Australia.
Lisa M Kaminskas1Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Pde, ParkvilleVIC, 3052, Australia; 2ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Melbourne, VIC, 3052, Australia; 3School of Biomedical Sciences, University of Queensland, St LuciaQLD, 4072, Australia.
Michael Whittaker1Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Pde, ParkvilleVIC, 3052, Australia; 2ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Melbourne, VIC, 3052, Australia; 3School of Biomedical Sciences, University of Queensland, St LuciaQLD, 4072, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoly(d,l-lactide-co-glycolide) (PLGA) based biodegradable nanoparticles are of key interest for the development of controlled release drug delivery systems and for other biomedical applications. It has been reported that PLGA polymers can be converted into colloidal nanoparticulate systems by various techniques, such as emulsification-diffusion, emulsification-evaporation, interfacial deposition, salting out, dialysis and nanoprecipitation. Emulsification-evaporation with water immisci-ble solvents including dichloromethane and chloroform has been the preferred method for the synthesis of PLGA nanoparticles due to the low boiling point and limited water solubility of these solvents. We and others, however, have found that when water-immiscible solvents are used for the synthesis of PLGA nanoparticles, particle aggregation, non-uniform particle size and multimodal size distribution are commonly encountered problems. This suggests that the synthesis of PLGA nanoparticles using water immiscible solvents is highly sensitive to small procedural variations that affect overall reproduc-ibility.

objectiveThis study presents a simple and robust procedure for the preparation of PLGA nanoparti-cles with very small batch to batch variability (<5% variability in size (z-average) as determined by dynamic light scattering).

resultsThe results showed that the emulsification solvent diffusion method teamed with partially water-miscible solvents, such as ethyl acetate, is a versatile approach for the preparation of PLGA na-noparticles with highly reproducible sizes (between 50 and 400 nm) and zeta potentials (between -30 and +30 mV), with relatively narrow polydispersity.

conclusionEmulsification-diffusion with ethyl acetate is, therefore, a more reliable alternative to sev-eral existing procedures for the reproducible and refined synthesis of PLGA nanoparticles.

Indexed as

drug deliveryemulsionethyl acetatenanoparticlesPLGAsolvent diffusion

Identifiers

PMID30532669
PMCPMC6225335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.